Literature DB >> 11063924

Treatment response in depressed patients with enhanced Ca mobilization stimulated by serotonin.

I Kusumi1, K Suzuki, Y Sasaki, K Kameda, T Koyama.   

Abstract

Serotonin (5-HT)-stimulated intraplatelet calcium (Ca) mobilization has been shown to be enhanced in nonmedicated depressive patients by many studies. However, there has not been any longitudinal follow-up study of this parameter. We examined the relationship between treatment response and pretreatment value of the 5-HT-induced Ca response. The 5-HT(10 microM)-induced intraplatelet Ca mobilization was measured in 98 nonmedicated depressive patients (24 bipolar disorders, 51 melancholic major depressive disorders, and 23 non-melancholic major depressive disorders). These patients were followed up prospectively for a further period of five years. The depressed patients with enhanced Ca response to 5-HT in bipolar disorders exhibited a good response to mood stabilizers but those with major depressive disorders showed a poor response to antidepressants. These findings suggest the possibility that the 5-HT-induced intraplatelet Ca response may be a good predictor of treatment response in depressed patients. Longer longitudinal follow-up studies are needed in larger samples to examine if this parameter may be a specific biological marker for unipolar-bipolar dichotomy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063924     DOI: 10.1016/S0893-133X(00)00149-4

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  3 in total

1.  Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets.

Authors:  Tatsuyuki Akimoto; Ichiro Kusumi; Katsuji Suzuki; Takuya Masui; Tsukasa Koyama
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

2.  Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial.

Authors:  Boadie W Dunlop; Elisabeth B Binder; Joseph F Cubells; Mark M Goodman; Mary E Kelley; Becky Kinkead; Michael Kutner; Charles B Nemeroff; D Jeffrey Newport; Michael J Owens; Thaddeus W W Pace; James C Ritchie; Vivianne Aponte Rivera; Drew Westen; W Edward Craighead; Helen S Mayberg
Journal:  Trials       Date:  2012-07-09       Impact factor: 2.279

3.  Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells.

Authors:  Tomoki Tada; Kensaku Aki; Wataru Oboshi; Kazuyoshi Kawazoe; Toshiyuki Yasui; Eiji Hosoi
Journal:  Drug Des Devel Ther       Date:  2016-09-26       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.